
News|Articles|February 1, 2002
- Pharmaceutical Technology-02-02-2002
- Volume 26
- Issue 2
Microbial Bioburden on Oral Solid Dosage Forms
Author(s)José E. Martinez
Low levels of some microorganisms that are present in oral solid dosage forms are unlikely to present a risk to patients. The amount of water activity in these products can help determine when microbiological testing should be conducted.
Advertisement
Articles in this issue
about 24 years ago
Using Earned-Value Analysis to Better Manage Projectsabout 24 years ago
Modernizing Pharmaceutical Manufacturingabout 24 years ago
The Role of Computational Fluid Dynamics in the Pharmaceutical Industryabout 24 years ago
Outsourcing OutlookNewsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Advertisement
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
FDA Launches PreCheck Pilot Program to Bolster Domestic Drug Manufacturing
2
FDA Grants Priority Review to AZ's Datroway for Metastatic Triple Negative Breast Cancer
3
Bristol Myers Squibb and Johnson & Johnson Launch Educational Program for Thromboembolic R&D
4
Cellares Scales IDMO Model for Gene-Edited Stem Cells Therapies
5




